Benitec Biopharma Inc.
NASDAQ:BNTCBiotechnology
Healthcare
$8.27 +3.05%
+$0.36 today
- Market cap
- $288.53M
- Beta
- 0.28
- P/E (TTM)
- -12.3
- EPS (TTM)
- -$0.99
52W Low $9.85High $16.76
Volume 0.13M
Average 0.11M
Balance Sheet
Inspect the capital base behind the business.
Assets
$99.59M
FY 2025 · Annual
+90.8% YoYLiabilities
$2.30M
FY 2025 · Annual
-53.7% YoYEquity
$97.30M
FY 2025 · Annual
+105.9% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $184.8M |
| Receivables | $3.0K |
| Other Current | $1.3M |
| Total Current Assets | $186.0M |
| PP&E (Net) | $916.0K |
| Other Non-current | $67.0K |
| Total Non-current Assets | $983.0K |
| Total Assets | $187.0M |
Analysis
Selected assets total $187.0M for Latest. The largest visible component is Cash & Equivalents at $184.8M, about 98.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 13, 2026 | |
| 8-K | Current report | Oct 28, 2026 | |
| DEFA14A | DEFA14A filing | Oct 20, 2026 | |
| DEF 14A | DEF 14A filing | Oct 20, 2026 |
How much cash does BNTC have?
Benitec Biopharma Inc. (BNTC) reported $97.74M in cash and equivalents in fiscal 2025.
How much debt does BNTC carry?
Benitec Biopharma Inc. (BNTC) reported $849,000.00 of total debt, with net debt of -$96.89M.
Continue the stock analysis
Jump to another research area for this company.